{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:55:45Z","timestamp":1793778945712,"version":"4.6.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a chronic immune-mediated skin disease associated with systemic comorbidities such as cardiovascular disease and depression. While genetic susceptibility, immune dysregulation, and environmental factors are known contributors, the precise etiology remains uncertain. This study uses data from the Global Burden of Disease (GBD 2021) database to examine global and regional trends in psoriasis incidence, prevalence, and disability-adjusted life years (DALYs), analyzing differences by gender, age, and region to guide public health planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from GBD 2021, covering 204 countries and regions, were used to estimate psoriasis incidence, prevalence, and DALYs through the DisMod-MR 2.1 model with Bayesian meta-regression to integrate multiple data sources. Annual average percentage change (AAPC) was calculated to analyze trends from 1990 to 2021, with future projections for the next 15\u202fyears based on a Bayesian age-period-cohort model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2021, global psoriasis prevalence increased from 23.06 million to 42.98 million (an 86% rise), and incidence grew by 80% from 2.85 million to 5.10 million cases. Psoriasis-related DALYs rose from 2 million to 3.69 million (an 85% increase). Regions with high Socio-demographic Index (SDI) values, including Western Europe, high-income North America, and Andean Latin America, exhibited significantly higher prevalence, incidence, and DALY rates compared to low-SDI regions such as East Asia and Sub-Saharan Africa. The burden was marginally higher in males than females, with the largest disparities in middle-aged males (40\u201360\u202fyears). A positive correlation between SDI and psoriasis burden was observed, showing that higher socioeconomic regions bear a greater disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global psoriasis burden continues to increase, particularly in high-SDI regions, where aging populations and greater healthcare access coexist. Projections indicate that psoriasis burden will rise over the next 15\u202fyears, especially among male patients. Enhanced early diagnosis, personalized treatment, and management of comorbidities are essential to reduce psoriasis\u2019s long-term health impacts and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1518681","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:45:09Z","timestamp":1752126309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data"],"prefix":"10.3389","volume":"13","author":[{"given":"Jikui","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiankuo","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The psychosocial burden of psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/jid.2009.319","article-title":"Molecular dissection of psoriasis: integrating genetics and biology","volume":"130","author":"Elder","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Diseases","year":"2024","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R package for an integrated evaluation of statistical approaches to cancer incidence projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12885-022-09923-4","article-title":"Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/1744666X.2020.1719833","article-title":"Epidemiology of major chronic inflammatory immune-related skin diseases in 2019","volume":"16","author":"Pezzolo","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/ijms23147499","article-title":"Exploring the links between obesity and psoriasis: a comprehensive review","volume":"23","author":"Barros","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.gene.6364351","article-title":"Psoriasis: genetic associations and immune system changes","volume":"8","author":"Liu","year":"2007","journal-title":"Genes Immun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/JW9.0000000000000112","article-title":"Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists","volume":"9","author":"Gonzalez-Cantero","year":"2023","journal-title":"Int J Womens Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/bjd.13288","article-title":"Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences","volume":"172","author":"Danielsen","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40266-020-00790-x","article-title":"Optimizing the treatment of moderate-to-severe psoriasis in older adults","volume":"37","author":"Shary","year":"2020","journal-title":"Drugs Aging"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"743180","DOI":"10.3389\/fmed.2021.743180","article-title":"The global, regional, and National Burden of psoriasis: results and insights from the global burden of disease 2019 study","volume":"8","author":"Damiani","year":"2021","journal-title":"Front Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","article-title":"Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030","volume":"316","author":"Wang","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","article-title":"Psoriasis and cardiovascular risk: a comprehensive review","volume":"37","author":"Masson","year":"2020","journal-title":"Adv Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/ijd.17236","article-title":"Disparities and barriers to the access of biologics in moderate-to-severe adult psoriasis","volume":"63","author":"Wan","year":"2024","journal-title":"Int J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s13555-021-00590-0","article-title":"Psoriasis and Cardiometabolic comorbidities: an evaluation of the impact of systemic treatments in randomized clinical trials","volume":"11","author":"Mosca","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3390\/jcm13082441","article-title":"The impact of shared assistance between dermatology and internal medicine on patients with psoriasis","volume":"13","author":"Garcia-Malinis","year":"2024","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/biology11060808","article-title":"Risks of biologic therapy and the importance of multidisciplinary approach for an accurate Management of Patients with moderate-severe psoriasis and concomitant Diseases","volume":"11","author":"Ion","year":"2022","journal-title":"Biology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1518681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:38:24Z","timestamp":1752154704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1518681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2025.1518681"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1518681","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1038\/s41598-026-48639-4","asserted-by":"object"}]},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1518681"}}